Global use of Haemophilus influenzae type b conjugate vaccine.
about
Accelerating introduction of new vaccines: barriers to introduction and lessons learned from the recent Haemophilus influenzae type B vaccine experienceThe potential impact of pneumococcal conjugate vaccine in Africa: Considerations and early lessons learned from the South African experienceChildhood pneumonia and crowding, bed-sharing and nutrition: a case-control study from The GambiaComparative economic evaluation of Haemophilus influenzae type b vaccination in Belarus and Uzbekistan.Implementing new health interventions in developing countries: why do we lose a decade or more?Vaccines and global health.Integrating pneumonia prevention and treatment interventions with immunization services in resource-poor countries.Measurement and valuation of health providers' time for the management of childhood pneumonia in rural Malawi: an empirical study.The effectiveness of conjugate Haemophilus influenzae type B vaccine in The Gambia 14 years after introduction.The seroepidemiology of Haemophilus influenzae type b prior to introduction of an immunization programme in Kathmandu, Nepal.Establishing global policy recommendations: the role of the Strategic Advisory Group of Experts on immunization.Treatment of bacterial meningitis: an update.Glycoconjugate vaccines: an update.Cost-effectiveness of Haemophilus influenzae type b conjugate vaccine in low- and middle-income countries: regional analysis and assessment of major determinants.Using social network analysis to examine the decision-making process on new vaccine introduction in Nigeria.Experimental design to optimize an Haemophilus influenzae type b conjugate vaccine made with hydrazide-derivatized tetanus toxoid.
P2860
Q26849683-521ED084-D479-40C3-9FE0-6A671A508296Q28088507-B75CE88F-CF4D-4C22-A9E9-C0B6C8EB9C35Q28595927-C998EC1B-CE05-46FE-8E25-70BDD6DDB0A3Q33947953-6555D196-AA54-489A-848C-E27873FB8402Q34386553-895D418B-4C85-4620-B4F6-76962FB9C811Q35137116-B697DCC7-6A9A-4677-A34A-EC2898BF0182Q35884745-DAC239DE-432D-4387-ADEB-4736ECC9D892Q36087645-31EB5490-A134-4374-AB76-801E2501F246Q37272305-16572EE6-AA9D-4C3C-AE79-FB412CCA5A00Q37504676-48B9AF3B-0BF0-4EC2-B0AF-65B9D643369DQ37844534-9AE29A51-BB0A-408C-AF23-5DBEB74F1CDFQ38044024-44D44F01-7818-46AD-B7E9-373D168BD484Q38286346-59021EC9-A6C7-4E65-A335-31AE2D8C440CQ39033442-4EB754FA-3A04-492A-A062-358310B191BFQ46892916-3B012D58-E547-4300-A8B2-38C2A9A71FCDQ51539230-04EE8F73-2D4F-4F77-A8C8-D9E049D93C77
P2860
Global use of Haemophilus influenzae type b conjugate vaccine.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Global use of Haemophilus influenzae type b conjugate vaccine.
@ast
Global use of Haemophilus influenzae type b conjugate vaccine.
@en
Global use of Haemophilus influenzae type b conjugate vaccine.
@nl
type
label
Global use of Haemophilus influenzae type b conjugate vaccine.
@ast
Global use of Haemophilus influenzae type b conjugate vaccine.
@en
Global use of Haemophilus influenzae type b conjugate vaccine.
@nl
prefLabel
Global use of Haemophilus influenzae type b conjugate vaccine.
@ast
Global use of Haemophilus influenzae type b conjugate vaccine.
@en
Global use of Haemophilus influenzae type b conjugate vaccine.
@nl
P2093
P1433
P1476
Global use of Haemophilus influenzae type b conjugate vaccine.
@en
P2093
Adam L Cohen
Allyson P Bear
Jennifer D Loo
Karen M Edmond
Linda R Ojo
Lois Privor-Dumm
Rana Hajjeh
Rosalyn E O'Loughlin
Sharmila S Shetty
Ulla K Griffiths
P304
P356
10.1016/J.VACCINE.2010.07.074
P407
P577
2010-08-04T00:00:00Z